| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 3.24e-08 | 16 | 122 | 5 | GO:0005041 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 1.48e-07 | 21 | 122 | 5 | GO:0030228 | |
| GeneOntologyMolecularFunction | growth factor binding | 5.26e-06 | 156 | 122 | 8 | GO:0019838 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 1.74e-04 | 85 | 122 | 5 | GO:0038024 | |
| GeneOntologyMolecularFunction | olfactory receptor binding | 5.47e-04 | 6 | 122 | 2 | GO:0031849 | |
| GeneOntologyBiologicalProcess | positive regulation of lysosomal protein catabolic process | 1.81e-06 | 5 | 118 | 3 | GO:1905167 | |
| GeneOntologyBiologicalProcess | positive regulation of protein catabolic process in the vacuole | 6.28e-06 | 7 | 118 | 3 | GO:1904352 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | GPC1 ONECUT2 SPRY1 RHBDF2 ITGA8 ACVR1B PTPRU TSPAN9 ADAMTS12 BMPR1B EGF EGFR WFIKKN2 LRP1 LRP2 PRMT1 HES1 PLAUR AGRN SORL1 | 1.24e-05 | 1186 | 118 | 20 | GO:0007167 |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | GPC1 ONECUT2 SPRY1 ITGA8 ADAMTS12 WFIKKN2 LRP1 LRP2 PRMT1 HES1 SORL1 | 2.49e-05 | 412 | 118 | 11 | GO:0090287 |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | ONECUT2 SPRY1 ITGA8 ACVR1B WFIKKN2 LRP1 LRP2 PRMT1 HES1 SORL1 | 3.11e-05 | 347 | 118 | 10 | GO:0090092 |
| GeneOntologyBiologicalProcess | regulation of lysosomal protein catabolic process | 3.87e-05 | 12 | 118 | 3 | GO:1905165 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | ONECUT2 SPRY1 ITGA8 ACVR1B BMPR1B WFIKKN2 LRP1 LRP2 PRMT1 HES1 SORL1 | 5.02e-05 | 445 | 118 | 11 | GO:0141091 |
| GeneOntologyBiologicalProcess | glial cell activation | 5.06e-05 | 70 | 118 | 5 | GO:0061900 | |
| GeneOntologyBiologicalProcess | negative regulation of hydrolase activity | 5.49e-05 | 298 | 118 | 9 | GO:0051346 | |
| GeneOntologyBiologicalProcess | regulation of protein catabolic process in the vacuole | 6.35e-05 | 14 | 118 | 3 | GO:1904350 | |
| GeneOntologyBiologicalProcess | cellular response to fatty acid | 9.63e-05 | 42 | 118 | 4 | GO:0071398 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | ONECUT2 SPRY1 ITGA8 ACVR1B BMPR1B WFIKKN2 LRP1 LRP2 PRMT1 HES1 SORL1 | 1.02e-04 | 482 | 118 | 11 | GO:0007178 |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | GPC1 ONECUT2 SPRY1 ITGA8 ACVR1B CPS1 ADAMTS12 BMPR1B EGFR WFIKKN2 LRP1 LRP2 PRMT1 HES1 SORL1 | 1.03e-04 | 850 | 118 | 15 | GO:0071363 |
| GeneOntologyBiologicalProcess | response to growth factor | GPC1 ONECUT2 SPRY1 ITGA8 ACVR1B CPS1 ADAMTS12 BMPR1B EGFR WFIKKN2 LRP1 LRP2 PRMT1 HES1 SORL1 | 1.56e-04 | 883 | 118 | 15 | GO:0070848 |
| GeneOntologyBiologicalProcess | negative regulation of lymphoid progenitor cell differentiation | 1.93e-04 | 4 | 118 | 2 | GO:1905457 | |
| GeneOntologyCellularComponent | cell surface | SELE GPC1 RTP1 ANK3 RTP2 ITGA8 ACVR1B ULBP3 LDLR EGFR TLR3 LRP1 LRP2 PLAUR CTSB AGRN UNC5D SORL1 | 7.06e-05 | 1111 | 121 | 18 | GO:0009986 |
| GeneOntologyCellularComponent | clathrin-coated endocytic vesicle membrane | 9.57e-05 | 79 | 121 | 5 | GO:0030669 | |
| GeneOntologyCellularComponent | clathrin-coated endocytic vesicle | 3.04e-04 | 101 | 121 | 5 | GO:0045334 | |
| GeneOntologyCellularComponent | alpha DNA polymerase:primase complex | 3.29e-04 | 5 | 121 | 2 | GO:0005658 | |
| GeneOntologyCellularComponent | endosome | GPC1 CLEC18A CLEC18B CARMIL1 CLEC18C BIRC6 LDLR RPS6KC1 TYRP1 EGFR ABCA5 TLR3 LRP1 LRP2 TRAPPC10 CTSB SORL1 | 3.99e-04 | 1167 | 121 | 17 | GO:0005768 |
| GeneOntologyCellularComponent | nuclear envelope | ZNF383 POLA1 SYNE1 INTS1 RB1CC1 FAF1 EGFR CCNI PCID2 KPNA1 SORL1 | 4.14e-04 | 560 | 121 | 11 | GO:0005635 |
| GeneOntologyCellularComponent | extracellular matrix | GPC1 ADAMTSL1 ADAMTSL3 TSPAN9 ADAMTS12 TLR3 ALB LGR6 CTSB MUC5AC AGRN MUC6 | 4.28e-04 | 656 | 121 | 12 | GO:0031012 |
| GeneOntologyCellularComponent | Golgi lumen | 4.32e-04 | 109 | 121 | 5 | GO:0005796 | |
| GeneOntologyCellularComponent | external encapsulating structure | GPC1 ADAMTSL1 ADAMTSL3 TSPAN9 ADAMTS12 TLR3 ALB LGR6 CTSB MUC5AC AGRN MUC6 | 4.39e-04 | 658 | 121 | 12 | GO:0030312 |
| GeneOntologyCellularComponent | endolysosome | 6.85e-04 | 30 | 121 | 3 | GO:0036019 | |
| GeneOntologyCellularComponent | lysosome | GPC1 ANK3 RB1CC1 LDLR RPS6KC1 EGF ABCA5 TLR3 LRP1 LRP2 PRMT1 CTSB AGRN | 8.48e-04 | 811 | 121 | 13 | GO:0005764 |
| GeneOntologyCellularComponent | lytic vacuole | GPC1 ANK3 RB1CC1 LDLR RPS6KC1 EGF ABCA5 TLR3 LRP1 LRP2 PRMT1 CTSB AGRN | 8.48e-04 | 811 | 121 | 13 | GO:0000323 |
| GeneOntologyCellularComponent | clathrin-coated pit | 1.20e-03 | 80 | 121 | 4 | GO:0005905 | |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 1.48e-03 | 212 | 121 | 6 | GO:0030666 | |
| GeneOntologyCellularComponent | clathrin-coated vesicle membrane | 1.66e-03 | 147 | 121 | 5 | GO:0030665 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 1.71e-03 | 88 | 121 | 4 | GO:0016529 | |
| GeneOntologyCellularComponent | serine/threonine protein kinase complex | 2.21e-03 | 157 | 121 | 5 | GO:1902554 | |
| GeneOntologyCellularComponent | axonal growth cone | 2.25e-03 | 45 | 121 | 3 | GO:0044295 | |
| GeneOntologyCellularComponent | vacuole | GPC1 ANK3 RB1CC1 LDLR RPS6KC1 EGF ABCA5 TLR3 LRP1 LRP2 PRMT1 CTSB AGRN | 2.44e-03 | 913 | 121 | 13 | GO:0005773 |
| GeneOntologyCellularComponent | keratin filament | 2.45e-03 | 97 | 121 | 4 | GO:0045095 | |
| GeneOntologyCellularComponent | clathrin-coated vesicle | 2.59e-03 | 237 | 121 | 6 | GO:0030136 | |
| Domain | Ldl_recept_b | 1.70e-10 | 14 | 119 | 6 | PF00058 | |
| Domain | LDLRB | 1.70e-10 | 14 | 119 | 6 | PS51120 | |
| Domain | LY | 2.81e-10 | 15 | 119 | 6 | SM00135 | |
| Domain | LDLR_classB_rpt | 2.81e-10 | 15 | 119 | 6 | IPR000033 | |
| Domain | EGF_3 | SELE CLEC18A CLEC18B CLEC18C LRP1B LDLR FAT2 EGF LRP1 LRP2 C9 AGRN SORL1 | 3.42e-09 | 235 | 119 | 13 | PS50026 |
| Domain | EGF-like_dom | SELE CLEC18A CLEC18B CLEC18C LRP1B LDLR FAT2 EGF LRP1 LRP2 C9 AGRN SORL1 | 6.86e-09 | 249 | 119 | 13 | IPR000742 |
| Domain | EGF-like_CS | SELE CLEC18A CLEC18B CLEC18C LRP1B LDLR FAT2 EGF LRP1 LRP2 C9 AGRN SORL1 | 1.20e-08 | 261 | 119 | 13 | IPR013032 |
| Domain | EGF_2 | SELE CLEC18A CLEC18B CLEC18C LRP1B LDLR FAT2 EGF LRP1 LRP2 C9 AGRN SORL1 | 1.44e-08 | 265 | 119 | 13 | PS01186 |
| Domain | EGF | SELE CLEC18A CLEC18B CLEC18C LRP1B LDLR FAT2 EGF LRP1 LRP2 AGRN SORL1 | 3.44e-08 | 235 | 119 | 12 | SM00181 |
| Domain | EGF_1 | SELE CLEC18A CLEC18B CLEC18C LRP1B LDLR FAT2 EGF LRP1 LRP2 C9 AGRN | 8.44e-08 | 255 | 119 | 12 | PS00022 |
| Domain | - | 1.62e-07 | 39 | 119 | 6 | 2.120.10.30 | |
| Domain | LDLR_class-A_CS | 1.90e-07 | 40 | 119 | 6 | IPR023415 | |
| Domain | Ldl_recept_a | 3.92e-07 | 45 | 119 | 6 | PF00057 | |
| Domain | 6-blade_b-propeller_TolB-like | 4.48e-07 | 46 | 119 | 6 | IPR011042 | |
| Domain | - | 4.48e-07 | 46 | 119 | 6 | 4.10.400.10 | |
| Domain | LDLRA_1 | 5.81e-07 | 48 | 119 | 6 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 6.59e-07 | 49 | 119 | 6 | IPR002172 | |
| Domain | LDLa | 6.59e-07 | 49 | 119 | 6 | SM00192 | |
| Domain | LDLRA_2 | 6.59e-07 | 49 | 119 | 6 | PS50068 | |
| Domain | EGF_CA | 1.31e-05 | 122 | 119 | 7 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.45e-05 | 124 | 119 | 7 | IPR001881 | |
| Domain | EGF | 1.61e-05 | 126 | 119 | 7 | PF00008 | |
| Domain | SCGB | 2.06e-05 | 9 | 119 | 3 | PS51311 | |
| Domain | Uteroglobin | 2.93e-05 | 10 | 119 | 3 | PF01099 | |
| Domain | Secretoglobin | 4.01e-05 | 11 | 119 | 3 | IPR016126 | |
| Domain | DUF5050 | 4.03e-05 | 2 | 119 | 2 | IPR032485 | |
| Domain | Secretoglobin_1C1/2 | 4.03e-05 | 2 | 119 | 2 | IPR028659 | |
| Domain | DUF5050 | 4.03e-05 | 2 | 119 | 2 | PF16472 | |
| Domain | TSP_1 | 5.05e-05 | 63 | 119 | 5 | PF00090 | |
| Domain | TSP1 | 5.87e-05 | 65 | 119 | 5 | SM00209 | |
| Domain | TSP1_rpt | 5.87e-05 | 65 | 119 | 5 | IPR000884 | |
| Domain | TSP1 | 5.87e-05 | 65 | 119 | 5 | PS50092 | |
| Domain | Growth_fac_rcpt_ | 6.35e-05 | 156 | 119 | 7 | IPR009030 | |
| Domain | TIL_dom | 8.72e-05 | 14 | 119 | 3 | IPR002919 | |
| Domain | CAP | 1.09e-04 | 15 | 119 | 3 | PF00188 | |
| Domain | SCP | 1.09e-04 | 15 | 119 | 3 | SM00198 | |
| Domain | Allrgn_V5/Tpx1 | 1.09e-04 | 15 | 119 | 3 | IPR001283 | |
| Domain | - | 1.09e-04 | 15 | 119 | 3 | 3.40.33.10 | |
| Domain | CAP_domain | 1.09e-04 | 15 | 119 | 3 | IPR014044 | |
| Domain | C-type_lectin_CS | 1.60e-04 | 43 | 119 | 4 | IPR018378 | |
| Domain | EGF_CA | 2.23e-04 | 86 | 119 | 5 | PF07645 | |
| Domain | PLAC | 2.27e-04 | 19 | 119 | 3 | PS50900 | |
| Domain | PLAC | 2.27e-04 | 19 | 119 | 3 | IPR010909 | |
| Domain | EGF_Ca-bd_CS | 3.90e-04 | 97 | 119 | 5 | IPR018097 | |
| Domain | R-trans_p | 3.98e-04 | 5 | 119 | 2 | IPR026096 | |
| Domain | EGF_CA | 4.28e-04 | 99 | 119 | 5 | PS01187 | |
| Domain | ASX_HYDROXYL | 4.49e-04 | 100 | 119 | 5 | PS00010 | |
| Domain | Peptidase_M12B_ADAM-TS | 4.63e-04 | 24 | 119 | 3 | IPR013273 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 5.86e-04 | 106 | 119 | 5 | IPR000152 | |
| Domain | cEGF | 5.89e-04 | 26 | 119 | 3 | PF12662 | |
| Domain | cEGF | 5.89e-04 | 26 | 119 | 3 | IPR026823 | |
| Domain | GS_dom | 8.28e-04 | 7 | 119 | 2 | IPR003605 | |
| Domain | GS | 8.28e-04 | 7 | 119 | 2 | PS51256 | |
| Domain | zf-3CxxC | 8.28e-04 | 7 | 119 | 2 | PF13695 | |
| Domain | TGF_beta_GS | 8.28e-04 | 7 | 119 | 2 | PF08515 | |
| Domain | GS | 8.28e-04 | 7 | 119 | 2 | SM00467 | |
| Domain | Arm | 9.95e-04 | 31 | 119 | 3 | PF00514 | |
| Domain | zf-3CxxC | 1.10e-03 | 8 | 119 | 2 | SM01328 | |
| Domain | Znf-3CxxC | 1.10e-03 | 8 | 119 | 2 | IPR027377 | |
| Domain | ZU5 | 1.41e-03 | 9 | 119 | 2 | SM00218 | |
| Domain | C_TYPE_LECTIN_1 | 1.71e-03 | 80 | 119 | 4 | PS00615 | |
| Domain | Activin_recp | 1.75e-03 | 10 | 119 | 2 | PF01064 | |
| Domain | Activin_recp | 1.75e-03 | 10 | 119 | 2 | IPR000472 | |
| Domain | ZU5 | 1.75e-03 | 10 | 119 | 2 | PS51145 | |
| Domain | Keratin_B2_2 | 1.95e-03 | 39 | 119 | 3 | PF13885 | |
| Domain | Lectin_C | 2.04e-03 | 84 | 119 | 4 | PF00059 | |
| Domain | CLECT | 2.04e-03 | 84 | 119 | 4 | SM00034 | |
| Domain | ARM_REPEAT | 2.10e-03 | 40 | 119 | 3 | PS50176 | |
| Domain | ARM | 2.10e-03 | 40 | 119 | 3 | SM00185 | |
| Domain | C_TYPE_LECTIN_2 | 2.13e-03 | 85 | 119 | 4 | PS50041 | |
| Domain | C-type_lectin-like | 2.23e-03 | 86 | 119 | 4 | IPR001304 | |
| Domain | TGFB_receptor | 2.55e-03 | 12 | 119 | 2 | IPR000333 | |
| Domain | C8 | 2.55e-03 | 12 | 119 | 2 | PF08742 | |
| Domain | TIL | 2.55e-03 | 12 | 119 | 2 | PF01826 | |
| Domain | ZU5 | 2.55e-03 | 12 | 119 | 2 | PF00791 | |
| Domain | ZU5_dom | 2.55e-03 | 12 | 119 | 2 | IPR000906 | |
| Domain | Unchr_dom_Cys-rich | 3.00e-03 | 13 | 119 | 2 | IPR014853 | |
| Domain | C8 | 3.00e-03 | 13 | 119 | 2 | SM00832 | |
| Domain | Armadillo | 3.33e-03 | 47 | 119 | 3 | IPR000225 | |
| Domain | - | 3.44e-03 | 97 | 119 | 4 | 3.10.100.10 | |
| Domain | PLAC | 3.48e-03 | 14 | 119 | 2 | PF08686 | |
| Domain | TUDOR | 3.48e-03 | 14 | 119 | 2 | PF00567 | |
| Domain | C-type_lectin-like/link | 3.70e-03 | 99 | 119 | 4 | IPR016186 | |
| Domain | VWF_type-D | 4.56e-03 | 16 | 119 | 2 | IPR001846 | |
| Domain | VWFD | 4.56e-03 | 16 | 119 | 2 | PS51233 | |
| Domain | VWD | 4.56e-03 | 16 | 119 | 2 | SM00216 | |
| Domain | VWD | 4.56e-03 | 16 | 119 | 2 | PF00094 | |
| Domain | CTDL_fold | 4.88e-03 | 107 | 119 | 4 | IPR016187 | |
| Domain | KAP | 6.03e-03 | 58 | 119 | 3 | IPR002494 | |
| Domain | ARM-type_fold | 6.04e-03 | 339 | 119 | 7 | IPR016024 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 1.05e-05 | 48 | 86 | 5 | M27642 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 2.63e-05 | 143 | 86 | 7 | M27275 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 5.79e-05 | 68 | 86 | 5 | M27303 | |
| Pathway | BIOCARTA_SPRY_PATHWAY | 1.16e-04 | 16 | 86 | 3 | MM1500 | |
| Pathway | BIOCARTA_SPRY_PATHWAY | 1.40e-04 | 17 | 86 | 3 | M1389 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 1.59e-04 | 45 | 86 | 4 | MM15344 | |
| Pathway | WP_RETINOBLASTOMA_GENE_IN_CANCER | 2.20e-04 | 90 | 86 | 5 | M39678 | |
| Pathway | WP_COMPLEMENT_SYSTEM | 2.97e-04 | 96 | 86 | 5 | M39581 | |
| Pathway | REACTOME_E2F_MEDIATED_REGULATION_OF_DNA_REPLICATION | 3.10e-04 | 22 | 86 | 3 | M6768 | |
| Pathway | REACTOME_DNA_REPLICATION_PRE_INITIATION | 3.12e-04 | 97 | 86 | 5 | MM15369 | |
| Pathway | REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_RSV_ATTACHMENT_AND_ENTRY | 3.55e-04 | 23 | 86 | 3 | M48234 | |
| Pathway | REACTOME_VISUAL_PHOTOTRANSDUCTION | 3.59e-04 | 100 | 86 | 5 | M27158 | |
| Pathway | BIOCARTA_ERBB3_PATHWAY | 3.64e-04 | 5 | 86 | 2 | M22018 | |
| Pathway | REACTOME_G1_S_TRANSITION | 4.30e-04 | 104 | 86 | 5 | MM15376 | |
| Pathway | WP_G1_TO_S_CELL_CYCLE_CONTROL | 5.17e-04 | 61 | 86 | 4 | MM15912 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 5.34e-04 | 109 | 86 | 5 | MM15164 | |
| Pathway | BIOCARTA_EEA1_PATHWAY | 5.43e-04 | 6 | 86 | 2 | MM1577 | |
| Pathway | BIOCARTA_ERBB3_PATHWAY | 5.43e-04 | 6 | 86 | 2 | MM1543 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 5.80e-04 | 111 | 86 | 5 | M27416 | |
| Pathway | WP_G1_TO_S_CELL_CYCLE_CONTROL | 6.21e-04 | 64 | 86 | 4 | M39627 | |
| Pathway | BIOCARTA_EEA1_PATHWAY | 7.57e-04 | 7 | 86 | 2 | M22064 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_JAK_STAT_SIGNALING_PATHWAY | 7.57e-04 | 7 | 86 | 2 | M47430 | |
| Pathway | KEGG_MEDICUS_VARIANT_ERBB2_OVEREXPRESSION_TO_EGF_JAK_STAT_SIGNALING_PATHWAY | 7.57e-04 | 7 | 86 | 2 | M47431 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 8.28e-04 | 250 | 86 | 7 | M27554 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | GPC1 CDKN1A CACNA1S KRT78 ANK3 RBBP5 RPS2 PSMB10 ITGA8 ACVR1B KRTAP10-7 KRTAP10-6 KRTAP10-12 TYRP1 EGF EGFR HES1 AGRN UNC5D | 8.53e-04 | 1432 | 86 | 19 | M509 |
| Pathway | REACTOME_EGFR_DOWNREGULATION | 8.71e-04 | 31 | 86 | 3 | MM14705 | |
| Pathway | REACTOME_EGFR_DOWNREGULATION | 8.71e-04 | 31 | 86 | 3 | M16597 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX | 9.57e-04 | 32 | 86 | 3 | MM15368 | |
| Pathway | REACTOME_DNA_REPLICATION | 9.93e-04 | 125 | 86 | 5 | MM15380 | |
| Pathway | REACTOME_DNA_REPLICATION_INITIATION | 1.01e-03 | 8 | 86 | 2 | MM15367 | |
| Pathway | REACTOME_DNA_REPLICATION_INITIATION | 1.01e-03 | 8 | 86 | 2 | M27664 | |
| Pathway | KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 1.01e-03 | 8 | 86 | 2 | M47498 | |
| Pathway | PID_E2F_PATHWAY | 1.02e-03 | 73 | 86 | 4 | M40 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX | 1.05e-03 | 33 | 86 | 3 | M9694 | |
| Pathway | REACTOME_MITOTIC_G1_PHASE_AND_G1_S_TRANSITION | 1.18e-03 | 130 | 86 | 5 | MM15146 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PI3K_SIGNALING_PATHWAY | 1.29e-03 | 9 | 86 | 2 | M47392 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ATR_P21_CELL_CYCLE_G2_M | 1.29e-03 | 9 | 86 | 2 | M47586 | |
| Pathway | REACTOME_EGFR_INTERACTS_WITH_PHOSPHOLIPASE_C_GAMMA | 1.29e-03 | 9 | 86 | 2 | M27133 | |
| Pathway | REACTOME_ASSEMBLY_OF_THE_ORC_COMPLEX_AT_THE_ORIGIN_OF_REPLICATION | 1.29e-03 | 9 | 86 | 2 | MM15358 | |
| Pathway | REACTOME_EGFR_INTERACTS_WITH_PHOSPHOLIPASE_C_GAMMA | 1.29e-03 | 9 | 86 | 2 | MM14853 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | IPPK RBBP5 POLA1 INTS1 OBSCN UNC93A ACVR1B BIRC6 ITPR2 RPS6KC1 IVNS1ABP DQX1 TLR3 LRP2 ALB ATM LONRF2 BANK1 | 1.50e-10 | 736 | 124 | 18 | 29676528 |
| Pubmed | Cigarette smoke augments MUC5AC production via the TLR3-EGFR pathway in airway epithelial cells. | 4.42e-08 | 3 | 124 | 3 | 26100173 | |
| Pubmed | 4.42e-08 | 3 | 124 | 3 | 16336259 | ||
| Pubmed | Endosomal TLR3 co-receptor CLEC18A enhances host immune response to viral infection. | 4.42e-08 | 3 | 124 | 3 | 33603190 | |
| Pubmed | Human CLEC18 Gene Cluster Contains C-type Lectins with Differential Glycan-binding Specificity. | 4.42e-08 | 3 | 124 | 3 | 26170455 | |
| Pubmed | Rhinovirus-induced major airway mucin production involves a novel TLR3-EGFR-dependent pathway. | 4.42e-08 | 3 | 124 | 3 | 18978302 | |
| Pubmed | 1.76e-07 | 4 | 124 | 3 | 16709836 | ||
| Pubmed | 2.11e-07 | 37 | 124 | 5 | 22432025 | ||
| Pubmed | 4.40e-07 | 5 | 124 | 3 | 19047013 | ||
| Pubmed | 4.40e-07 | 5 | 124 | 3 | 18685438 | ||
| Pubmed | 8.78e-07 | 6 | 124 | 3 | 9837937 | ||
| Pubmed | 8.78e-07 | 6 | 124 | 3 | 1426645 | ||
| Pubmed | hSpry2 is targeted to the ubiquitin-dependent proteasome pathway by c-Cbl. | 8.78e-07 | 6 | 124 | 3 | 12593796 | |
| Pubmed | MESD is essential for apical localization of megalin/LRP2 in the visceral endoderm. | 8.79e-07 | 21 | 124 | 4 | 21337463 | |
| Pubmed | 1.07e-06 | 22 | 124 | 4 | 12768436 | ||
| Pubmed | 1.53e-06 | 7 | 124 | 3 | 8798151 | ||
| Pubmed | 1.53e-06 | 7 | 124 | 3 | 12169628 | ||
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 1.75e-06 | 101 | 124 | 6 | 23382219 | |
| Pubmed | 2.45e-06 | 8 | 124 | 3 | 20302655 | ||
| Pubmed | 2.45e-06 | 8 | 124 | 3 | 35025664 | ||
| Pubmed | Stabilization of beta-catenin affects mouse embryonic liver growth and hepatoblast fate. | 3.41e-06 | 29 | 124 | 4 | 18038450 | |
| Pubmed | 3.66e-06 | 9 | 124 | 3 | 20005821 | ||
| Pubmed | 5.73e-06 | 71 | 124 | 5 | 33541421 | ||
| Pubmed | A mouse knockout library for secreted and transmembrane proteins. | CLEC18A ADAMTSL1 CLEC18B TMEM50A INTS1 CLEC18C ADAMTS12 TLR3 ALB LGR6 | 6.33e-06 | 460 | 124 | 10 | 20562862 |
| Pubmed | Sprouty2 acts at the Cbl/CIN85 interface to inhibit epidermal growth factor receptor downregulation. | 7.15e-06 | 11 | 124 | 3 | 15962011 | |
| Pubmed | 7.15e-06 | 11 | 124 | 3 | 24639464 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | RHBDF2 RTTN INTS1 OBSCN PSMB10 RHOT2 BIRC6 LDLR ITPR2 PPP1R26 ORC1 ZNF263 HERC1 AGRN PRRT4 | 9.74e-06 | 1105 | 124 | 15 | 35748872 |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 22087246 | ||
| Pubmed | Striking differences of LDL receptor-related protein 1B expression in mouse and human. | 1.26e-05 | 2 | 124 | 2 | 15963947 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 20382126 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 23222817 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 7951532 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 17889283 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 28643125 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 18285671 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 26313756 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 23486467 | ||
| Pubmed | The role of EGF-EGFR signalling pathway in hepatocellular carcinoma inflammatory microenvironment. | 1.26e-05 | 2 | 124 | 2 | 24268047 | |
| Pubmed | Upregulation of hepatic LDL transport by n-3 fatty acids in LDL receptor knockout mice. | 1.26e-05 | 2 | 124 | 2 | 11971949 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 33933428 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 27179806 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 1728582 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 17334773 | ||
| Pubmed | Megalin/gp330 mediates uptake of albumin in renal proximal tubule. | 1.26e-05 | 2 | 124 | 2 | 8898021 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 26009168 | ||
| Pubmed | Epidermal growth factor as a biologic switch in hair growth cycle. | 1.26e-05 | 2 | 124 | 2 | 12714603 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 28586385 | ||
| Pubmed | LRP: role in vascular wall integrity and protection from atherosclerosis. | 1.26e-05 | 2 | 124 | 2 | 12690199 | |
| Pubmed | Clinical significance of EGF and EGFR expression changes in cryptorchid boys. | 1.26e-05 | 2 | 124 | 2 | 12508124 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 28486782 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 33921304 | ||
| Pubmed | Heterogeneity in EGF-binding affinities arises from negative cooperativity in an aggregating system. | 1.26e-05 | 2 | 124 | 2 | 18165319 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 8076525 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 11988092 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 18456456 | ||
| Pubmed | Epidermal growth factor mutant with wild-type affinity for both ErbB1 and ErbB3. | 1.26e-05 | 2 | 124 | 2 | 16584205 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 8036006 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 33576385 | ||
| Pubmed | LRP1 regulates remodeling of the extracellular matrix by fibroblasts. | 1.26e-05 | 2 | 124 | 2 | 19699300 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 34445520 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 7640657 | ||
| Pubmed | Detection of epidermal growth factor-urogastrone and its receptor during fetal mouse development. | 1.26e-05 | 2 | 124 | 2 | 6248866 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 15100232 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 29277356 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 25837250 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 11336639 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 17337084 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 9422745 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 31906817 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 15016552 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 25453753 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 12360467 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 25416211 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 28934307 | ||
| Pubmed | ATM and p21 cooperate to suppress aneuploidy and subsequent tumor development. | 1.26e-05 | 2 | 124 | 2 | 16204044 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 17148666 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 10575007 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 9890455 | ||
| Pubmed | Small tandem DNA duplications result from CST-guided Pol α-primase action at DNA break termini. | 1.26e-05 | 2 | 124 | 2 | 34376693 | |
| Pubmed | Role of epidermal growth factor and its receptor in chemotherapy-induced intestinal injury. | 1.26e-05 | 2 | 124 | 2 | 11841993 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 21822280 | ||
| Pubmed | Safe and Effective Sarcoma Therapy through Bispecific Targeting of EGFR and uPAR. | 1.26e-05 | 2 | 124 | 2 | 28193671 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 25872475 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 24704591 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 17709443 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 35410600 | ||
| Pubmed | EGFR genomic gain and aberrant pathway signaling in pancreatic cancer patients. | 1.26e-05 | 2 | 124 | 2 | 17950068 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 26079101 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 12388817 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 38892470 | ||
| Pubmed | Rhinovirus induces MUC5AC in a human infection model and in vitro via NF-κB and EGFR pathways. | 1.26e-05 | 2 | 124 | 2 | 20525715 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 12162747 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 21670278 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 28019699 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 30611716 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 9405657 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 28321513 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 30226622 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 26057128 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 17223314 | ||
| Interaction | ZFP41 interactions | 5.15e-08 | 57 | 122 | 7 | int:ZFP41 | |
| Interaction | ZNF563 interactions | 6.09e-07 | 12 | 122 | 4 | int:ZNF563 | |
| Interaction | NR4A1 interactions | 6.64e-07 | 212 | 122 | 10 | int:NR4A1 | |
| Interaction | RNF123 interactions | IPPK RBBP5 POLA1 INTS1 OBSCN UNC93A ACVR1B BIRC6 ITPR2 RPS6KC1 IVNS1ABP DQX1 TLR3 LRP2 ALB ATM LONRF2 BANK1 | 2.33e-06 | 824 | 122 | 18 | int:RNF123 |
| Interaction | EGFL6 interactions | 7.06e-06 | 21 | 122 | 4 | int:EGFL6 | |
| Interaction | APOE interactions | 9.66e-06 | 171 | 122 | 8 | int:APOE | |
| Interaction | NTN5 interactions | 1.24e-05 | 24 | 122 | 4 | int:NTN5 | |
| Interaction | TAFA4 interactions | 2.04e-05 | 55 | 122 | 5 | int:TAFA4 | |
| Interaction | EXT1 interactions | 2.44e-05 | 57 | 122 | 5 | int:EXT1 | |
| Interaction | VHL interactions | CDKN1A RPS2 KDM5C RB1CC1 BIRC6 HNRNPH2 TDRD7 IVNS1ABP MEX3A EGFR DGKI PRMT1 ATM | 3.61e-05 | 561 | 122 | 13 | int:VHL |
| Interaction | ADGRG2 interactions | 4.58e-05 | 12 | 122 | 3 | int:ADGRG2 | |
| Interaction | IGFL3 interactions | 9.21e-05 | 75 | 122 | 5 | int:IGFL3 | |
| Interaction | CUBN interactions | 9.34e-05 | 15 | 122 | 3 | int:CUBN | |
| Interaction | CCN2 interactions | 9.87e-05 | 40 | 122 | 4 | int:CCN2 | |
| Interaction | ZNF264 interactions | 1.09e-04 | 41 | 122 | 4 | int:ZNF264 | |
| Interaction | TAFA3 interactions | 1.11e-04 | 78 | 122 | 5 | int:TAFA3 | |
| Interaction | LRPAP1 interactions | 1.14e-04 | 180 | 122 | 7 | int:LRPAP1 | |
| Interaction | DEFB123 interactions | 1.14e-04 | 16 | 122 | 3 | int:DEFB123 | |
| Cytoband | 21q22.3 | 4.18e-04 | 128 | 124 | 4 | 21q22.3 | |
| Cytoband | 6q25 | 4.69e-04 | 12 | 124 | 2 | 6q25 | |
| GeneFamily | Low density lipoprotein receptors | 4.73e-07 | 13 | 94 | 4 | 634 | |
| GeneFamily | Secretoglobins | 4.75e-05 | 14 | 94 | 3 | 734 | |
| GeneFamily | Zinc fingers 3CxxC-type|Receptor transporter proteins | 2.65e-04 | 5 | 94 | 2 | 719 | |
| GeneFamily | ADAMTS like | 5.52e-04 | 7 | 94 | 2 | 947 | |
| GeneFamily | Type 1 receptor serine/threonine kinases | 5.52e-04 | 7 | 94 | 2 | 345 | |
| GeneFamily | Zinc fingers 3CxxC-type|Receptor transporter proteins | 7.34e-04 | 8 | 94 | 2 | 137 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.44e-03 | 43 | 94 | 3 | 409 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.53e-03 | 161 | 94 | 5 | 593 | |
| GeneFamily | C-type lectin domain family | 1.87e-03 | 47 | 94 | 3 | 494 | |
| GeneFamily | CD molecules|Mucins | 5.27e-03 | 21 | 94 | 2 | 648 | |
| ToppCell | (9)_Platelet|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 6.62e-07 | 177 | 124 | 7 | 0830944c43de300815831a9e2b2fce40965e7d12 | |
| ToppCell | (9)_Platelet|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 6.62e-07 | 177 | 124 | 7 | e63d01c7fce4fa1256212fa7e95f74281edb3a01 | |
| ToppCell | megakaryocytic-Platelet|World / Lineage and Cell class | 7.41e-07 | 180 | 124 | 7 | c007c3e63c2bb35ed34327dd8863899b5db93115 | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.58e-07 | 184 | 124 | 7 | a5d904dd030d9c21be0f8b9ec432025f90fb5b8e | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.58e-07 | 184 | 124 | 7 | 7617a00b2ebd6c5c9386c39a7e8220fdbf8669ff | |
| ToppCell | PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.14e-06 | 192 | 124 | 7 | f14ee74ac3275601749a23c5efe39c2413a62e1a | |
| ToppCell | PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.14e-06 | 192 | 124 | 7 | 0219093e7921a0db78053aee13ec480b520f5662 | |
| ToppCell | NS-control-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.45e-06 | 199 | 124 | 7 | 32bdfff40fd442b88489c8b0f79af3927a51a03c | |
| ToppCell | control-Epithelial-Secretory|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.45e-06 | 199 | 124 | 7 | 262e5b8a52c8ddb0b47048c786e8bdb7158e1b9a | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 1.50e-06 | 200 | 124 | 7 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_3|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.83e-06 | 131 | 124 | 6 | aeeb5718b3a7122492ad2659d5c8112f60839ff3 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a7-Tac2-Excitatory_Neuron.Slc17a7.Tac2.Chat_(Habenular_cholinergic_cells)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.38e-06 | 82 | 124 | 5 | 51dd9ab3ddb26d3d3395d0c1a156a12a86caf89b | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Rln3_(parabrachial_pigmented_nucleus_(PBP))-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 4.78e-06 | 88 | 124 | 5 | b4620e79ea80681305434707e87cb02a7c6a5e4f | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Rln3_(parabrachial_pigmented_nucleus_(PBP))--|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 4.78e-06 | 88 | 124 | 5 | 7992f8e621edf464bffcb70a6cc5f3b60c1d96f8 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Rln3_(parabrachial_pigmented_nucleus_(PBP))|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 4.78e-06 | 88 | 124 | 5 | b7b55f51af8ffa82813a4747580985a430da9ed1 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.03e-06 | 161 | 124 | 6 | 60f433eab9d5531bdf6aa86b0265f20b866b904c | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.24e-06 | 162 | 124 | 6 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.94e-06 | 165 | 124 | 6 | 6799a6580c667738995cceb31cbf1c7fbdc4ff84 | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.94e-06 | 165 | 124 | 6 | 8329d780f244bc31344443b29e5a00529a016662 | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 7.69e-06 | 168 | 124 | 6 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.23e-06 | 170 | 124 | 6 | 417b77c12a7982b1ce4b4bc57f30335d261220f5 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-hematologic-thrombocytic|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.80e-06 | 172 | 124 | 6 | 1a9b99c7fc297d9e4b6098bf0c4fb98927a05f6d | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-hematologic-thrombocytic-platelet|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.80e-06 | 172 | 124 | 6 | d588ca825ab301910c1378e009b766c809b0bd5e | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.39e-06 | 174 | 124 | 6 | 3f0a5ce074675d57d479fa069385a1b3071e884e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.00e-05 | 176 | 124 | 6 | 6c7edf1cb38644500bce6c5a1dd90bbe17415cdb | |
| ToppCell | IIF-Other-Platelet|IIF / Disease, Lineage and Cell Type | 1.07e-05 | 178 | 124 | 6 | 529c0d2159e539546876246122f2e999170a6b20 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-05 | 178 | 124 | 6 | 51d2188406f04329311b2efd1108fc36617a860e | |
| ToppCell | 3'_v3-blood-Hematopoietic_Erythro-Mega-Megakaryocyte_early|blood / Manually curated celltypes from each tissue | 1.10e-05 | 179 | 124 | 6 | 290772eece76d70555dca8b8d82bd88b47e2fc35 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-05 | 184 | 124 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-05 | 184 | 124 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-05 | 184 | 124 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.33e-05 | 185 | 124 | 6 | 8ed10ba581849c9c4ac4397226be2b62b4b3b900 | |
| ToppCell | PBMC-Control-Hematopoietic|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.33e-05 | 185 | 124 | 6 | c95c77d4302d7fff7fdef1774f15a93ba9ced61a | |
| ToppCell | PBMC-Control-Hematopoietic|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.33e-05 | 185 | 124 | 6 | 72a281ef246de5b30de1241d792c25bfae60e797 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.33e-05 | 185 | 124 | 6 | b8052cebb73f41abe6faf0aa847be7c8ef23ae94 | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.37e-05 | 186 | 124 | 6 | 3bf38c80d892a73391009b426dec8ae26a027351 | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.37e-05 | 186 | 124 | 6 | 107bc473f5e57238390f8e0ab9f7263a8f93948c | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.37e-05 | 186 | 124 | 6 | 7496137cebc191aecd1e6ae7fa33118b128fbfe6 | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.37e-05 | 186 | 124 | 6 | 9c2fd0bbc968c317a763f52e72fa7182c3c49850 | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.37e-05 | 186 | 124 | 6 | 13a9ddcf93b0c4319ab9d484af5e2056e9754caa | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.37e-05 | 186 | 124 | 6 | 06281df5e9665ccc510279bf7e552845c63d5dab | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.37e-05 | 186 | 124 | 6 | c2b65b8345487710704c3eb043e9bef2e2b1ff27 | |
| ToppCell | facs-Lung-EPCAM-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-05 | 186 | 124 | 6 | 7c4eb769574f9f32753cea1cc38c711dabba88b9 | |
| ToppCell | Control-Hematopoietic_Mega-Platelet|Control / Disease group, lineage and cell class | 1.41e-05 | 187 | 124 | 6 | 53e9665e1feb02ce8fe78ff4128fd4beacef8471 | |
| ToppCell | Control-Hematopoietic_Mega|Control / Disease group, lineage and cell class | 1.41e-05 | 187 | 124 | 6 | 7bf98bdc83feb3918dbcf12e87a64fe4d2d41eba | |
| ToppCell | COVID-19-kidney-CD-IC-B|kidney / Disease (COVID-19 only), tissue and cell type | 1.41e-05 | 187 | 124 | 6 | ce05b89860573fe0356102e2998d1ef6d1968034 | |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | 1.50e-05 | 189 | 124 | 6 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 1.50e-05 | 189 | 124 | 6 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | Healthy-Platelet|Healthy / disease group, cell group and cell class | 1.50e-05 | 189 | 124 | 6 | 5863e132536594e49bffbb637454cc43dfdbaa20 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.55e-05 | 190 | 124 | 6 | 1bbbf0ce222e51f9fd2daca0c18d3965fd4efd31 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.64e-05 | 192 | 124 | 6 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | IPF-Epithelial-Basal|World / Disease state, Lineage and Cell class | 1.64e-05 | 192 | 124 | 6 | 9b91e0b162e6f3ce86dd15cc33c2e745d069581f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-05 | 194 | 124 | 6 | be869e186386d03ebb670971dd24fa656b4b0edf | |
| ToppCell | control-Myeloid-Non-resident_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.90e-05 | 197 | 124 | 6 | df2fe36cb96e2565a9d21c24cb4e451e8befd4be | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.01e-05 | 199 | 124 | 6 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.01e-05 | 199 | 124 | 6 | 6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c | |
| ToppCell | Control-Control-Others|Control / Disease, condition lineage and cell class | 2.01e-05 | 199 | 124 | 6 | b7e83772fdd466e1bd0ae13af9ac477e7595ae14 | |
| ToppCell | control-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.01e-05 | 199 | 124 | 6 | 3d01f90ffd271ca00129192787e4921bdca7e01e | |
| ToppCell | Tracheal-NucSeq-Stromal-Chondrocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.07e-05 | 200 | 124 | 6 | b5a54b9baf79aea01f76a161f0a39bbe87eb4945 | |
| ToppCell | Tracheal-NucSeq-Stromal-Chondrocytic-Chondrocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.07e-05 | 200 | 124 | 6 | f5bd0b30e478dac09f68c46b0781f5f2e7e3c693 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Basal_1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 2.07e-05 | 200 | 124 | 6 | 592c7c3ded409a9957cbcdc62fcc213fa8eae598 | |
| ToppCell | Control-Control-Others-Platelet|Control / Disease, condition lineage and cell class | 2.07e-05 | 200 | 124 | 6 | e0463c93714ab5fd00f294cca83bd61027fe0e95 | |
| ToppCell | LPS_IL1RA-Hematopoietic_Erythro-Megakary-Erythro-Mega|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.07e-05 | 200 | 124 | 6 | f99e214eb680fd82a33f2b1524fbfca265d1cc42 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.07e-05 | 200 | 124 | 6 | 8cfbde43c5e66269ad128aa5398b1517667d7d36 | |
| ToppCell | LPS_IL1RA-Hematopoietic_Erythro-Megakary|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.07e-05 | 200 | 124 | 6 | d85074b362b11e5a523a5325d203a61aa2759a7a | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.07e-05 | 200 | 124 | 6 | 61811380d9252f12f27b7ad4752380b52692677f | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.86e-05 | 142 | 124 | 5 | e160f35b3c18e77c4107fe96db5f56227c91785e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.51e-05 | 151 | 124 | 5 | f4f7156b2c0cfc78fd1841e07c9915d97ced561f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.71e-05 | 152 | 124 | 5 | 655d47efe0608d729801f1f01668e84c1bc0675f | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_VISp_Col27a1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.14e-05 | 154 | 124 | 5 | d22902d2922784583f7016453768ed05b14b965e | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage_2|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.36e-05 | 155 | 124 | 5 | 84221a285277292f7225eb69508c887541abeed1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.55e-05 | 160 | 124 | 5 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.55e-05 | 160 | 124 | 5 | 56e6f4b82b5dc41c45f9d253c2db314a6f702b84 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.55e-05 | 160 | 124 | 5 | bb1b966fb9e801db15e67d03e49db4609d6f935a | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.55e-05 | 160 | 124 | 5 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | Basal_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 8.55e-05 | 160 | 124 | 5 | b223cc47e68a29df4758c5ccf8f6dbffe2a6fa1d | |
| ToppCell | droplet-Marrow-BM-30m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.61e-05 | 164 | 124 | 5 | b77995958c938e10a526118f75d78cee72e0b207 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-erythrocytic-erythroid_lineage_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.14e-04 | 170 | 124 | 5 | 288014dedda8babc51fe08e48a55e68d83e1b1d2 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.14e-04 | 170 | 124 | 5 | 4ce81608111b9ee7cb974dad2c182f38db3dcd79 | |
| ToppCell | Control-Classical_Monocyte-cMono_4|Classical_Monocyte / Disease condition and Cell class | 1.14e-04 | 170 | 124 | 5 | 9e328e1f904c77dcce8aee4df775d7f0ac725775 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 171 | 124 | 5 | 1eebd7138c3b20ddc1104f21615f9df0e776bbe6 | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.20e-04 | 172 | 124 | 5 | 7c238a7375341d4647ba7274d93fddfb6fae7ce4 | |
| ToppCell | facs-Heart-RA-3m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 173 | 124 | 5 | 49030c2dd04b592655df1a667e2f90efb499e0a5 | |
| ToppCell | facs-Heart-RA-3m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 173 | 124 | 5 | 1cfbab6603f8baf8e238837bb72740c43a7dc0ec | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-Double_negative_thymocyte,_DN3_(Cd8-,_Cd4-),_some_express_pre_TCR_alpha|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 174 | 124 | 5 | 0fccd90ef72ec2e5eb369fe6d6d126c60886485a | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-DN3_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 174 | 124 | 5 | b2fc2a756f8e373ad903bd416d9de703d945fa1c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-04 | 174 | 124 | 5 | 5f4436863a40f8bca46e2989bca66c02b6be88d4 | |
| ToppCell | PCW_13-14-Hematologic_ErythroMegGranulo-Hem_ErythroMeg|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.30e-04 | 175 | 124 | 5 | c33317d8d60ea88ec326daf91dfd3416a62f9938 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-04 | 175 | 124 | 5 | d8e385320f554d974538b7cdc4f8e4767f1455f2 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-04 | 175 | 124 | 5 | cf15465855602ba135752c18755e3e058dbd42ec | |
| ToppCell | facs-Trachea-24m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l54|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.34e-04 | 176 | 124 | 5 | 460cb302c5b3d609c65b924e1d4e8ea057a68485 | |
| ToppCell | Severe-CD4+_T_activated|World / Disease group and Cell class | 1.41e-04 | 178 | 124 | 5 | ef6111238703579a34bd6948bd9d4ca6b7e16063 | |
| ToppCell | PBMC-Convalescent-Hematopoietic-Platelet|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.41e-04 | 178 | 124 | 5 | f5d83ad082e31d5601890d245b9fb4f9ef6a062b | |
| ToppCell | PBMC-Convalescent-Hematopoietic-Platelet-Platelet|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.41e-04 | 178 | 124 | 5 | a2a8fc14f492a4695e6991a357b6626145f1bf7f | |
| ToppCell | PBMC-Convalescent-Hematopoietic-Platelet-Platelet|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.45e-04 | 179 | 124 | 5 | 510927794bbd21814eba75286e0801eb1fd2e8a6 | |
| ToppCell | PBMC-Convalescent-Hematopoietic|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.45e-04 | 179 | 124 | 5 | 3b1616e974ea7792ff5c37da3b0281f28edfbb56 | |
| ToppCell | PBMC-Convalescent-Hematopoietic|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.45e-04 | 179 | 124 | 5 | 35271a4396a533f6d960ce55d171a32d9d2fd1a4 | |
| ToppCell | PBMC-Convalescent-Hematopoietic-Platelet|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.45e-04 | 179 | 124 | 5 | 906a5ebbbac660b6fd498ced09d0ada40a3e64af | |
| ToppCell | COVID-19-kidney-Stressed_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.45e-04 | 179 | 124 | 5 | 754f69bac7a1d5137f5141f6193285ccbfe361cb | |
| ToppCell | 3'-Adult-Appendix-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.45e-04 | 179 | 124 | 5 | 2285e3a9018a60d7f6e974fee46b6f61d39aa76f | |
| Drug | monatepil | 4.18e-07 | 29 | 121 | 5 | CID000060810 | |
| Drug | Calpain inhibitor I | 2.57e-06 | 280 | 121 | 10 | CID000004332 | |
| Drug | Plant Preparations | 7.27e-06 | 315 | 121 | 10 | ctd:D028321 | |
| Drug | Guaifenesin [93-14-1]; Down 200; 20.2uM; HL60; HT_HG-U133A | 1.06e-05 | 197 | 121 | 8 | 2569_DN | |
| Drug | Hydroxamic Acids | 1.21e-05 | 27 | 121 | 4 | ctd:D006877 | |
| Drug | Gallic Acid | 1.32e-05 | 97 | 121 | 6 | ctd:D005707 | |
| Drug | sodium linoleate | 1.48e-05 | 342 | 121 | 10 | CID000003931 | |
| Drug | D-tryptophan methyl ester | 2.34e-05 | 11 | 121 | 3 | CID000077980 | |
| Drug | probucol | 2.59e-05 | 162 | 121 | 7 | CID000004912 | |
| Drug | 5-ethylbarbituric acid | 2.80e-05 | 2 | 121 | 2 | CID000017292 | |
| Drug | 5-phenylbarbituric acid | 2.80e-05 | 2 | 121 | 2 | CID000089646 | |
| Drug | Bio-Phe-Ala-CHN2 | 2.80e-05 | 2 | 121 | 2 | CID005483648 | |
| Drug | Vinca-type compound | 2.80e-05 | 2 | 121 | 2 | CID000494342 | |
| Drug | epicholesterol | SELE CPT1A PPBP LRP1B LDLR EGF EGFR ABCA5 TLR3 LRP1 LRP2 ALB SORL1 | 3.46e-05 | 636 | 121 | 13 | CID000000304 |
| Drug | Dicumarol | 3.50e-05 | 35 | 121 | 4 | ctd:D001728 | |
| Drug | SB 203580 | 4.34e-05 | 388 | 121 | 10 | ctd:C093642 | |
| Drug | tyrphostin AG 1478 | 4.86e-05 | 122 | 121 | 6 | ctd:C101044 | |
| Disease | Colorectal Carcinoma | SYNE1 OBSCN PTPRU ADAMTSL3 ZNHIT6 EGFR ABCA5 LRP1 LRP2 LGR6 LONRF2 ZNF471 SORL1 | 5.42e-06 | 702 | 119 | 13 | C0009402 |
| Disease | autosomal dominant polycystic kidney disease (is_marker_for) | 2.25e-05 | 14 | 119 | 3 | DOID:898 (is_marker_for) | |
| Disease | cataract | 2.38e-05 | 141 | 119 | 6 | MONDO_0005129 | |
| Disease | Prostatic Neoplasms | CDKN1A ONECUT2 LRP1B IVNS1ABP BMPR1B EGF EGFR LRP2 PLAUR ATM CTSB | 4.13e-05 | 616 | 119 | 11 | C0033578 |
| Disease | Malignant neoplasm of prostate | CDKN1A ONECUT2 LRP1B IVNS1ABP BMPR1B EGF EGFR LRP2 PLAUR ATM CTSB | 4.13e-05 | 616 | 119 | 11 | C0376358 |
| Disease | pancreatic cancer (is_marker_for) | 5.70e-05 | 101 | 119 | 5 | DOID:1793 (is_marker_for) | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 1.10e-04 | 61 | 119 | 4 | DOID:3587 (is_marker_for) | |
| Disease | creatinine measurement, glomerular filtration rate | 1.15e-04 | 117 | 119 | 5 | EFO_0004518, EFO_0005208 | |
| Disease | mucinous adenocarcinoma (is_marker_for) | 1.60e-04 | 5 | 119 | 2 | DOID:3030 (is_marker_for) | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 1.65e-04 | 200 | 119 | 6 | EFO_0004611, EFO_0020945 | |
| Disease | Malignant Neoplasms | 1.75e-04 | 128 | 119 | 5 | C0006826 | |
| Disease | hepatocellular carcinoma (is_marker_for) | 2.27e-04 | 301 | 119 | 7 | DOID:684 (is_marker_for) | |
| Disease | oral mucosa leukoplakia (is_marker_for) | 2.39e-04 | 6 | 119 | 2 | DOID:9655 (is_marker_for) | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 2.56e-04 | 139 | 119 | 5 | DOID:3908 (is_implicated_in) | |
| Disease | level of Sterol ester (27:1/20:4) in blood serum | 2.65e-04 | 31 | 119 | 3 | OBA_2045198 | |
| Disease | Glioblastoma | 2.99e-04 | 79 | 119 | 4 | C0017636 | |
| Disease | Childhood Oligodendroglioma | 3.34e-04 | 7 | 119 | 2 | C0280475 | |
| Disease | Adult Oligodendroglioma | 3.34e-04 | 7 | 119 | 2 | C0279070 | |
| Disease | autosomal dominant polycystic kidney disease (biomarker_via_orthology) | 3.34e-04 | 7 | 119 | 2 | DOID:898 (biomarker_via_orthology) | |
| Disease | Oligodendroblastoma | 3.34e-04 | 7 | 119 | 2 | C0344461 | |
| Disease | Mixed Oligodendroglioma-Astrocytoma | 3.34e-04 | 7 | 119 | 2 | C0280793 | |
| Disease | Mixed Oligodendroglioma-Ependymoma | 3.34e-04 | 7 | 119 | 2 | C0751395 | |
| Disease | Well Differentiated Oligodendroglioma | 3.34e-04 | 7 | 119 | 2 | C0751396 | |
| Disease | cervical cancer | 3.49e-04 | 34 | 119 | 3 | C4048328 | |
| Disease | Giant Cell Glioblastoma | 3.78e-04 | 84 | 119 | 4 | C0334588 | |
| Disease | mitochondrial DNA measurement | 3.81e-04 | 328 | 119 | 7 | EFO_0006312 | |
| Disease | Uterine Cervical Neoplasm | 3.81e-04 | 35 | 119 | 3 | C0007873 | |
| Disease | liver fibrosis measurement | 4.14e-04 | 86 | 119 | 4 | EFO_0010576 | |
| Disease | Paroxysmal atrial fibrillation | 4.36e-04 | 156 | 119 | 5 | C0235480 | |
| Disease | familial atrial fibrillation | 4.36e-04 | 156 | 119 | 5 | C3468561 | |
| Disease | Persistent atrial fibrillation | 4.36e-04 | 156 | 119 | 5 | C2585653 | |
| Disease | bilirubin measurement | 4.38e-04 | 442 | 119 | 8 | EFO_0004570 | |
| Disease | oligodendroglioma | 4.44e-04 | 8 | 119 | 2 | C0028945 | |
| Disease | PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME | 4.44e-04 | 8 | 119 | 2 | C0796250 | |
| Disease | Anaplastic Oligodendroglioma | 4.44e-04 | 8 | 119 | 2 | C0334590 | |
| Disease | Cataract | 4.50e-04 | 37 | 119 | 3 | C0086543 | |
| Disease | Kidney Diseases | 4.52e-04 | 88 | 119 | 4 | C0022658 | |
| Disease | platelet crit | CARMIL1 RTTN TENT5C CPS1 ITPR2 EGF EGFR DQX1 PRIM1 PLAUR MYEOV SORL1 | 4.77e-04 | 952 | 119 | 12 | EFO_0007985 |
| Disease | Atrial Fibrillation | 4.89e-04 | 160 | 119 | 5 | C0004238 | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 6.27e-04 | 169 | 119 | 5 | DOID:3908 (is_marker_for) | |
| Disease | renal cell carcinoma | 6.55e-04 | 42 | 119 | 3 | EFO_0000681 | |
| Disease | Human papillomavirus infectious disease (is_marker_for) | 7.11e-04 | 10 | 119 | 2 | DOID:11166 (is_marker_for) | |
| Disease | interventricular septum thickness | 7.11e-04 | 10 | 119 | 2 | EFO_0009287 | |
| Disease | Lung Neoplasms | 7.38e-04 | 265 | 119 | 6 | C0024121 | |
| Disease | schizophrenia (is_marker_for) | 7.51e-04 | 44 | 119 | 3 | DOID:5419 (is_marker_for) | |
| Disease | Malignant neoplasm of lung | 7.52e-04 | 266 | 119 | 6 | C0242379 | |
| Disease | atrial fibrillation | 7.88e-04 | 371 | 119 | 7 | EFO_0000275 | |
| Disease | HIV Infections | 8.17e-04 | 103 | 119 | 4 | C0019693 | |
| Disease | HIV Coinfection | 8.17e-04 | 103 | 119 | 4 | C4505456 | |
| Disease | tyrosine measurement | 8.47e-04 | 104 | 119 | 4 | EFO_0005058 | |
| Disease | Neoplasm Invasiveness | 9.19e-04 | 184 | 119 | 5 | C0027626 | |
| Disease | platelet component distribution width | SYNE1 CARMIL1 RTTN TENT5C CPS1 TSPAN9 EGF EGFR HERC1 SEC14L5 | 9.86e-04 | 755 | 119 | 10 | EFO_0007984 |
| Disease | lung adenocarcinoma (is_implicated_in) | 1.03e-03 | 49 | 119 | 3 | DOID:3910 (is_implicated_in) | |
| Disease | autoimmune thyroiditis (is_implicated_in) | 1.04e-03 | 12 | 119 | 2 | DOID:7188 (is_implicated_in) | |
| Disease | Papilloma | 1.04e-03 | 12 | 119 | 2 | C0030354 | |
| Disease | Papillomatosis | 1.04e-03 | 12 | 119 | 2 | C0205875 | |
| Disease | Papilloma, Squamous Cell | 1.04e-03 | 12 | 119 | 2 | C0205874 | |
| Disease | familial hyperlipidemia (implicated_via_orthology) | 1.04e-03 | 12 | 119 | 2 | DOID:1168 (implicated_via_orthology) | |
| Disease | Glioblastoma Multiforme | 1.08e-03 | 111 | 119 | 4 | C1621958 | |
| Disease | aspartate aminotransferase measurement | CDKN1A ONECUT2 CACNA1S RBBP5 CARMIL1 OBSCN BIRC6 TSPAN9 ADAMTS12 BANK1 ARMC6 | 1.10e-03 | 904 | 119 | 11 | EFO_0004736 |
| Disease | pneumonia, COVID-19 | 1.15e-03 | 113 | 119 | 4 | EFO_0003106, MONDO_0100096 | |
| Disease | gallbladder cancer (is_implicated_in) | 1.22e-03 | 13 | 119 | 2 | DOID:3121 (is_implicated_in) | |
| Disease | Hereditary Diffuse Gastric Cancer | 1.24e-03 | 293 | 119 | 6 | C1708349 | |
| Disease | Stomach Neoplasms | 1.33e-03 | 297 | 119 | 6 | C0038356 | |
| Disease | Mammary Carcinoma, Human | 1.33e-03 | 525 | 119 | 8 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 1.33e-03 | 525 | 119 | 8 | C1257931 | |
| Disease | Malignant neoplasm of breast | GPC1 RTP1 SYNE1 OBSCN RB1CC1 CPT1A EGF EGFR HES1 ATM LGR6 SORL1 | 1.35e-03 | 1074 | 119 | 12 | C0006142 |
| Disease | Mammary Neoplasms | 1.36e-03 | 527 | 119 | 8 | C1458155 | |
| Disease | Malignant neoplasm of stomach | 1.40e-03 | 300 | 119 | 6 | C0024623 | |
| Disease | gastric ulcer (implicated_via_orthology) | 1.42e-03 | 14 | 119 | 2 | DOID:10808 (implicated_via_orthology) | |
| Disease | membranous glomerulonephritis (biomarker_via_orthology) | 1.42e-03 | 14 | 119 | 2 | DOID:10976 (biomarker_via_orthology) | |
| Disease | optic disc size measurement | 1.48e-03 | 205 | 119 | 5 | EFO_0004832 | |
| Disease | Breast Carcinoma | 1.55e-03 | 538 | 119 | 8 | C0678222 | |
| Disease | asthma (is_marker_for) | 1.72e-03 | 126 | 119 | 4 | DOID:2841 (is_marker_for) | |
| Disease | asthma (biomarker_via_orthology) | 1.76e-03 | 59 | 119 | 3 | DOID:2841 (biomarker_via_orthology) | |
| Disease | platelet measurement | 1.79e-03 | 315 | 119 | 6 | EFO_0005036 | |
| Disease | Urticaria | 1.87e-03 | 16 | 119 | 2 | C0042109 | |
| Disease | Dermatitis | 1.87e-03 | 16 | 119 | 2 | C0011603 | |
| Disease | acute kidney failure (biomarker_via_orthology) | 1.94e-03 | 61 | 119 | 3 | DOID:3021 (biomarker_via_orthology) | |
| Disease | pre-malignant neoplasm (biomarker_via_orthology) | 2.11e-03 | 17 | 119 | 2 | DOID:0060071 (biomarker_via_orthology) | |
| Disease | otitis media (biomarker_via_orthology) | 2.11e-03 | 17 | 119 | 2 | DOID:10754 (biomarker_via_orthology) | |
| Disease | oral squamous cell carcinoma (is_marker_for) | 2.13e-03 | 63 | 119 | 3 | DOID:0050866 (is_marker_for) | |
| Disease | cholangiocarcinoma (is_marker_for) | 2.23e-03 | 64 | 119 | 3 | DOID:4947 (is_marker_for) | |
| Disease | pelvic organ prolapse | 2.28e-03 | 136 | 119 | 4 | EFO_0004710 | |
| Disease | creatinine measurement | CACNA1S OBSCN CPS1 BIRC6 LDLR TSPAN9 LRP2 MYEOV C9 CTSB SORL1 | 2.33e-03 | 995 | 119 | 11 | EFO_0004518 |
| Disease | lymphocyte count | IPPK CACNA1S CLEC18C CPS1 FAF1 ITPR2 EGF EGFR SCGB1C2 PLAUR MYEOV ATM KNL1 SCGB1C1 | 2.34e-03 | 1464 | 119 | 14 | EFO_0004587 |
| Disease | Bladder Neoplasm | 2.53e-03 | 140 | 119 | 4 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 2.59e-03 | 141 | 119 | 4 | C0005684 | |
| Disease | laryngeal squamous cell carcinoma (is_marker_for) | 2.64e-03 | 19 | 119 | 2 | DOID:2876 (is_marker_for) | |
| Disease | polycystic kidney disease (biomarker_via_orthology) | 2.64e-03 | 19 | 119 | 2 | DOID:0080322 (biomarker_via_orthology) | |
| Disease | Benign Neoplasm | 2.65e-03 | 68 | 119 | 3 | C0086692 | |
| Disease | Neoplasms | 2.65e-03 | 68 | 119 | 3 | C0027651 | |
| Disease | Abdominal Aortic Aneurysm | 2.65e-03 | 68 | 119 | 3 | EFO_0004214 | |
| Disease | citrulline measurement | 2.92e-03 | 20 | 119 | 2 | EFO_0009777 | |
| Disease | Adenocarcinoma of prostate | 2.92e-03 | 20 | 119 | 2 | C0007112 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 3.09e-03 | 148 | 119 | 4 | C0279702 | |
| Disease | Schizophrenia | ANK3 ITGA8 RB1CC1 ADAMTSL3 ADAMTS12 TLR3 LRP1 LRP2 ATM KPNA1 | 3.10e-03 | 883 | 119 | 10 | C0036341 |
| Disease | BREAST CANCER | 3.22e-03 | 21 | 119 | 2 | 114480 | |
| Disease | cerebellar cortex volume measurement | 3.22e-03 | 21 | 119 | 2 | EFO_0010291 | |
| Disease | blood pressure | 3.53e-03 | 22 | 119 | 2 | EFO_0004325 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IYMDSRAGCSKSCEA | 151 | Q8WWZ7 | |
| KECLFRMADSGESLC | 286 | Q8NDB2 | |
| SRDCDALMAGCIQEA | 31 | P38936 | |
| VATLRETYGEMADCC | 101 | P02768 | |
| SGDDRAMCFTCSVCL | 321 | Q9NR09 | |
| VEVSAEDLLTCCGSM | 131 | P07858 | |
| RCSCILNLEESMDSD | 56 | P0C853 | |
| CETDGACMVSIFNLD | 46 | P36896 | |
| MSERCCSRYSSGASI | 1 | Q6NXE6 | |
| CEADASAPATCAEMR | 891 | O00468 | |
| RDSFCGCSSSEILRM | 116 | Q14094 | |
| RSCTTESCDFVRAMV | 606 | P50416 | |
| GDLDTSLCDICMCSI | 326 | Q9P2G1 | |
| SLCDICMCSISVFED | 331 | Q9P2G1 | |
| ICSTDGYCFTMIEED | 46 | O00238 | |
| RRVECSTQMDSDCAA | 1336 | P58397 | |
| KGQLCELSCSTDYRM | 356 | Q99873 | |
| CDKDLDTLSGYAMCL | 101 | Q9H8X2 | |
| YEDGIERTCDTLLMC | 2471 | Q14571 | |
| ECMAADRRVCTYSAG | 51 | Q8TDY2 | |
| CATLSEYSRQCSMVG | 271 | Q6W4X9 | |
| MVRNSTRCYCEDGFE | 131 | Q9NZR2 | |
| ESDSICGAITCAADM | 2751 | Q9NZR2 | |
| GIMDACCESSDCLEI | 221 | Q9P1T7 | |
| LMSSAEECCRNLAFS | 2091 | Q8N201 | |
| CGDYLLSRMDVTSCI | 121 | Q9Y6Y0 | |
| DSCDSDAIERMYCAP | 956 | Q96S38 | |
| CQEDGIMLSADCSEL | 41 | Q9HBX8 | |
| CSEKMALSTASDDRC | 401 | P35052 | |
| FMVSGTECEECFLTC | 511 | Q9P107 | |
| ETTRSCMCTAGYSLR | 1866 | Q07954 | |
| EEVCRMASDYSRTCA | 341 | Q15751 | |
| GTRCYTESLDMCISG | 141 | Q8N6G6 | |
| MRALDFADESGSVSC | 6 | Q86SG4 | |
| SCSADEVMRFFSDCK | 21 | P55795 | |
| YTGDRCEMEARGCSE | 4016 | Q9NYQ8 | |
| LCCEYLAEATESSMG | 451 | Q6ZS72 | |
| TAYRCLTKDLEGCAM | 6 | O95948 | |
| LLEGEECRMSGECTS | 416 | Q8N1N4 | |
| ALCMTLAESSCPDYE | 216 | Q96EZ4 | |
| CSISCDRGYLPSSME | 206 | P16581 | |
| TTCTFDCEEGFELMG | 266 | P16581 | |
| SCTDNLEGSAMLLCD | 1336 | Q8NG31 | |
| FRCSCDTGYMLESDG | 1411 | P98164 | |
| SLDVTDFECALCMRL | 441 | Q1L5Z9 | |
| LSCSLDEARMSKDGC | 5501 | P98088 | |
| SRAFSYTEVEECGCM | 5601 | P98088 | |
| CTICMERLVTASGYE | 411 | Q86Y01 | |
| SCEFDCVDEMLTLAA | 481 | Q8TE96 | |
| TDMEPSLYRCSNIDC | 1301 | P09884 | |
| DSMTSAACFSLRVCA | 511 | P53708 | |
| EADGTLDCISMALTC | 16 | Q15291 | |
| RSGTFCACATVLEMI | 1386 | Q92729 | |
| MVDAAEYSCVCGEER | 3336 | Q5VST9 | |
| DMTDYDDVRRCCSSA | 111 | P49642 | |
| YREMCVKTEGCSTEI | 31 | Q13415 | |
| AAELLMSCFRVCASD | 141 | Q5JVF3 | |
| MSCFRVCASDTRAGI | 146 | Q5JVF3 | |
| SCVRACGADSYEMEE | 306 | P00533 | |
| SCIMDVSLRSFSLCC | 1481 | Q13315 | |
| TYMCRAGAIRTDDNC | 261 | Q8IUR7 | |
| RCEMASTGEVACFGE | 1326 | P31327 | |
| EVMFSSCLRCVSVED | 631 | Q9BX69 | |
| SCLRCVSVEDMAALA | 636 | Q9BX69 | |
| SMYARCISEGEDATC | 841 | P01133 | |
| RCTDLSKMTEEECRG | 956 | Q13698 | |
| VRGDCDLETCRMYID | 776 | O75912 | |
| AMSRCETCGTEEAKY | 216 | Q9NWK9 | |
| NDPVESSLRCFCMTD | 1321 | Q12955 | |
| MSVCSSDLSYGSRVC | 6 | P60371 | |
| MSVCSSDLSYGSRVC | 6 | P60409 | |
| MSVCSSDLSYGSRVC | 1 | P60413 | |
| DQRDGCECEMGTYLS | 221 | Q8TB03 | |
| DLSNTECSLDMVCGA | 371 | Q5VZK9 | |
| DDSMCLAESGLSYPC | 246 | Q9UNN5 | |
| CEVLASEDFRGSMSS | 651 | O43304 | |
| AMCEDCSEIPNLSYS | 916 | Q8TDX9 | |
| ESLDSDLYAELRCMC | 51 | P02775 | |
| MSACRSFAVAICILE | 1 | P02748 | |
| LELYGNEISSMECLC | 176 | Q8N309 | |
| ECMNEVTRFLSTCEG | 116 | Q14469 | |
| LCYECGTARLDESSM | 131 | P59025 | |
| CYECGTARLDESSML | 96 | Q5QGT7 | |
| TAAIDMFCTCAGLSA | 1771 | Q86VV8 | |
| TLTCMSREFQCEDGE | 1511 | Q92673 | |
| MSGFLEGLRCSECID | 1 | O95807 | |
| CTEDMRKSSCVESFD | 1936 | O60522 | |
| LACLVPMSEEDYSCA | 8761 | Q8NF91 | |
| SLDATCDVACLMFDG | 481 | Q8IXI1 | |
| MDFRTACEETKTGIC | 1 | Q9NSN8 | |
| IAGDSTMCRDYVLDC | 196 | P52294 | |
| ALTLFCICRMATGED | 11 | P0DMR2 | |
| SSCRADTSAELMCAE | 471 | Q5T8A7 | |
| YCCGAGVAADAEMTT | 81 | P40306 | |
| RSGEITCYAMACTET | 66 | Q8NHU6 | |
| YCTDVGADLLSMCQR | 231 | Q9BUU2 | |
| MAEESSCTRDCMSFS | 1 | Q5VWP2 | |
| TCDLRIDGDCFMVSS | 301 | A5D8T8 | |
| TCDLRIDGDCFMVSS | 301 | Q6UXF7 | |
| TCDLRIDGDCFMVSS | 301 | Q8NCF0 | |
| DGLFMEILSSCSDCD | 381 | Q9Y6X2 | |
| EMSDEDSCVACGSLR | 286 | Q2L4Q9 | |
| TLQVRMSCECEADGY | 121 | Q9BZM4 | |
| NVCDICTDDLMGSRS | 256 | P17643 | |
| SECTDVLMGRSSLNC | 106 | Q8N8Z8 | |
| DMRFNPFDCTCESIA | 641 | O15455 | |
| RSRYLECISCGSSDM | 111 | Q03405 | |
| LTRGLCSDLESMCET | 71 | Q8NA42 | |
| GRDCMVCFESEVTAA | 466 | A1L020 | |
| CYADSGCKLLEDMVE | 16 | O75556 | |
| LDCEMCLTSKGRELT | 231 | Q96IC2 | |
| EEQLTSCGASDCLMA | 171 | Q86WB7 | |
| FCGLSRDSSSMLLCS | 806 | C9JH25 | |
| RQCLCSAESMVEYGT | 206 | O43609 | |
| ALTLFCICRMATGED | 11 | Q8TD33 | |
| EVMSVEDESTSCYCL | 646 | Q6UXZ4 | |
| TRGLCSDLESMCETK | 101 | Q3KNS6 | |
| LICLDCAMESSRNSS | 176 | Q3LFD5 | |
| ACMEGITSYGLECST | 106 | Q9BX82 | |
| MSLLDCFCTSRTQVE | 1 | Q9C0K7 | |
| MEYCRTGSLCSLEVL | 1071 | P48553 | |
| MAGIDDCYTSARGCT | 216 | P15880 | |
| GSCEITTREYCEFMH | 606 | Q6PJF5 | |
| ECMECGKAFGRTSDL | 196 | Q7Z3V5 | |
| IQAEMRCCGVTDYTD | 141 | O75954 | |
| TLSAYMAEACGGCDL | 626 | A6NCI4 | |
| RCYMDAEACSKGITL | 156 | Q8TEU8 | |
| CSECGESFSRSSRLM | 661 | O14978 | |
| LDGTRCNTDSLDMCI | 181 | P82987 | |
| FIESYVCRMCSRGDE | 321 | P41229 | |
| GSRQCDREYDCKDMS | 251 | P01130 |